Implications of Elevated Fibrosis-4 Index in Patients Receiving Trans-Catheter Aortic Valve Replacement.

Teruhiko ImamuraNikhil NarangHiroshi OnodaShuhei TanakaRyuichi UshijimaMitsuo SobajimaNobuyuki FukudaHiroshi UenoKoichiro Kinugawa

Published in: Journal of clinical medicine (2021)

an elevated fibrosis-4 index at baseline, indicating the existence of persistent hepatic congestion, was associated with incidences of heart failure following TAVR. Calculating the fibrosis-4 index before TAVR is highly encouraged for risk stratification and shared decision making.

Keyphrases

aortic valve replacement
aortic stenosis
aortic valve
transcatheter aortic valve replacement
heart failure
transcatheter aortic valve implantation
ejection fraction
left ventricular
coronary artery disease
liver fibrosis
atrial fibrillation
cardiac resynchronization therapy